We are live on ! Find out more
GMO

General Moly, Inc.
GMO

Delisted

GMO was delisted on the 30th of September, 2020.

39 hedge funds and large institutions have $3.18M invested in General Moly, Inc. in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3939 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

28% less capital invested

Capital invested by funds: $4.43M → $3.18M (-$1.24M)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
39
Holders Change
Holders Change %
0%
% of All Funds
0.97%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
6
Reduced
9
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UOTTAIMCU
1
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$1.08M
Vanguard Group
2
Vanguard Group
Pennsylvania
$797K -$13.7K -40,070 -2%
BlackRock
3
BlackRock
New York
$579K -$51.3K -149,379 -9%
Bank of America
4
Bank of America
North Carolina
$119K +$14.6K +42,424 +15%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$97K
SIM
6
Sonora Investment Management
Arizona
$60.2K
EA
7
Evanston Advisors
Illinois
$55K +$892 +2,600 +2%
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$53K
Renaissance Technologies
9
Renaissance Technologies
New York
$47K +$7.68K +22,386 +22%
Northern Trust
10
Northern Trust
Illinois
$44K -$9.56K -27,863 -19%
Deutsche Bank
11
Deutsche Bank
Germany
$39K +$17.1K +49,776 +86%
Goldman Sachs
12
Goldman Sachs
New York
$34K -$1.63K -4,751 -5%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$31K -$1.38K -4,026 -5%
MBA
14
McQueen Ball & Associates
Pennsylvania
$21K
State Street
15
State Street
Massachusetts
$17K
UCFA
16
United Capital Financial Advisors
Texas
$15K
FIM
17
Fernwood Investment Management
Massachusetts
$14K -$8.47K -24,700 -39%
VKH
18
Virtu KCG Holdings
New York
$12K -$7.19K -20,957 -38%
Citadel Advisors
19
Citadel Advisors
Florida
$12K +$6.41K +18,690 +144%
KAM
20
Kazazian Asset Management
Florida
$8K
CAN
21
Cetera Advisor Networks
California
$7K
GC
22
Guggenheim Capital
Illinois
$7K
HIIFS
23
Harel Insurance Investments & Financial Services
Israel
$7K
LTFS
24
Ladenburg Thalmann Financial Services
Florida
$7K
DPA
25
Delphi Private Advisors
California
$6K +$5.15K +15,000 New

GMO Hedge Fund Activity: Q2 2017 in Review

39 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in General Moly, Inc. (GMO) for Q2 2017, worth a combined $3.18M — down 28% from $4.43M a quarter earlier.

Fund positioning in GMO was balanced in Q2 2017: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 9 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $17.1K. The largest seller was BlackRock, cutting an estimated $51.3K.

  • 39 institutional investors held General Moly, Inc. (GMO) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $3.18M of General Moly, Inc. stock for Q2 2017, down 28% quarter-over-quarter.
  • 3 funds opened new General Moly, Inc. positions in Q2 2017 and 3 closed out, a net change of 0 holders.
  • The largest General Moly, Inc. buyer in Q2 2017 was Deutsche Bank, an estimated $17.1K added.
  • The largest General Moly, Inc. seller in Q2 2017 was BlackRock, an estimated $51.3K sold.

Based on aggregated 13F filings for Q2 2017.